MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Dyadic International, Inc.

< Previous 1 2 Next >
News headline image
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Present at Investor Conferences and BPI East
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Present at World Vaccine Congress | Washington
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Attend Multiple Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Expands Global Presence with Participation in Key Industry Events
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Attend Industry Events in June
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Attend Industry and Investor Events in May
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Announces Change in Board and Management Leadership Roles
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Attend Industry Events in April
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
News headline image
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
Tickers DYAI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story